Combination of triazine derivatives and insulin secretion stimulators

Details for Australian Patent Application No. 2006334731 (hide)

Owner POXEL SAS

Inventors Cravo, Daniel; Mesangeau, Didier; Moinet, Gerard

Agent Davies Collison Cave

Pub. Number AU-B-2006334731

PCT Pub. Number WO2007/079914

Priority 06/00342 13.01.06 FR

Filing date 18 December 2006

Wipo publication date 19 July 2007

Acceptance publication date 21 June 2012

International Classifications

A61K 31/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61P 3/10 Drugs for disorders of the metabolism

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/079914 Priority application(s): WO2007/079914

16 July 2009 Assignment before Grant

  Merck Patent GmbH The application has been assigned to POXEL SAS

21 June 2012 Application Accepted

  Published as AU-B-2006334731

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006334732-Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect

2006334728-Vibration damper comprising a protection against stones